TNF-alpha in asthma.

Abstract:

:Although only 5-10% of patients with asthma are relatively unresponsive to treatment with inhaled corticosteroids, refractory asthma represents an important condition, as these patients suffer considerable morbidity and mortality and consume a disproportionately large amount of health resource. Treatment options are limited and there is a large unmet clinical need for additional therapies. Tumour necrosis factor (TNF)-alpha is a pro-inflammatory cytokine that has been implicated in many aspects of the airway pathology in asthma, and which has recently been highlighted as potentially important in refractory asthma. The development of neutralising biological agents against TNF-alpha has allowed us to test the role of this cytokine in vivo. Preliminary studies have demonstrated an improvement in lung function, airway hyperresponsiveness and asthma quality-of-life, together with a reduction in exacerbation frequency, in patients treated with anti-TNF-alpha therapy.

journal_name

Curr Opin Pharmacol

authors

Berry M,Brightling C,Pavord I,Wardlaw A

doi

10.1016/j.coph.2007.03.001

subject

Has Abstract

pub_date

2007-06-01 00:00:00

pages

279-82

issue

3

eissn

1471-4892

issn

1471-4973

pii

S1471-4892(07)00063-X

journal_volume

7

pub_type

杂志文章,评审
  • Small molecule drugs - optimizing DNA damaging agent-based therapeutics.

    abstract::DNA-targeted chemotherapies remain fundamental in clinical management of both common solid tumours and hematologic malignancies. Recent studies indicate that novel combinations of cytotoxic chemotherapy may have significant activity even in tumours regarded as being resistant to conventional chemotherapy. In addition,...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.03.008

    authors: Hartley JA,Hochhauser D

    更新日期:2012-08-01 00:00:00

  • Current drug development portfolio for antimalarial therapies.

    abstract::In response to the emergence of parasite drug resistance to currently deployed antimalarials, the scientific community, in partnership with the pharmaceutical industry and public organizations, has fashioned an antimalarial drug development portfolio for the sustained development and registration of safe, effective an...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.05.004

    authors: Biagini GA,O'Neill PM,Bray PG,Ward SA

    更新日期:2005-10-01 00:00:00

  • New approaches to targeting the bone marrow microenvironment in multiple myeloma.

    abstract::Multiple myeloma is a tumour with a remarkably destructive effect on its host organ, the bone marrow. Through expression or secretion of adhesion molecules, growth factors, exosomes, miRNAs, chemokines and inhibitors, the tumour substantially alters its microenvironment, promoting both tumour survival and osteolytic b...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.02.013

    authors: Gooding S,Edwards CM

    更新日期:2016-06-01 00:00:00

  • HIV protease inhibitors in gut barrier dysfunction and liver injury.

    abstract::The development of HIV protease inhibitors (HIV PIs) has been one of the most significant advances of the past two decades in controlling HIV infection. HIV PIs have been used successfully in highly active anti-retroviral therapy (HAART) for HIV infection, which is currently the most effective treatment available. Inc...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.07.008

    authors: Wu X,Li Y,Peng K,Zhou H

    更新日期:2014-12-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections.

    abstract::High occurrence of penicillin-resistant and multidrug-resistant Streptococcus pneumoniae and reports of resistance with Haemophilus influenzae and Moraxella catarrhalis are influencing the empiric treatment of community-acquired respiratory infections and allowing the new fluoroquinolones to serve as important treatme...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00080-7

    authors: Zhanel GG,Noreddin AM

    更新日期:2001-10-01 00:00:00

  • Impact of ∼omics in the detection and validation of potential anti-infective drugs.

    abstract::New anti-infective drugs are an unmet necessity of modern medicine. The use of ∼omics technologies has exponentially increased the knowledge on active anti-infective structures, where to search for them and their mechanisms of action. Research involving extreme and unique environments (such as endophytes) revealed the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.02.008

    authors: Maldonado-Carmona N,Vázquez-Hernández M,Patiño Chávez OJ,Rodríguez-Luna SD,Jiménez Rodríguez O,Sanchez S,Ceapă CD

    更新日期:2019-10-01 00:00:00

  • The bacterial ribosome, a promising focus for structure-based drug design.

    abstract::Recent crystal structures of the bacterial ribosome have identified the complex molecular interactions involved in antibiotic-ribosome recognition. Insights into the binding of aminoglycosides, macrolides, tetracyclines and other antibiotics provide opportunities for computational, structure-based approaches to be use...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00205-9

    authors: Knowles DJ,Foloppe N,Matassova NB,Murchie AI

    更新日期:2002-10-01 00:00:00

  • Two way communication between neutrophils and dendritic cells.

    abstract::Neutrophils are instrumental in innate immunity by mediating immediate removal of pathogens. Recent findings demonstrate that they are able to communicate with dendritic cells, which form a link between innate and adaptive immunity by stimulating long-term memory T cell responses. This communication occurs through the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.03.009

    authors: Ludwig IS,Geijtenbeek TB,van Kooyk Y

    更新日期:2006-08-01 00:00:00

  • Treatment of orthostatic hypotension.

    abstract::Orthostatic hypotension (OH) is a fall in blood pressure after assuming an upright position. Whereas asymptomatic patients usually need no treatment, the majority of symptomatic patients can be cured by avoidance of trigger mechanisms and the use of physical countermaneuvers and non-pharmacological interventions. Seve...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00213-8

    authors: Oldenburg O,Kribben A,Baumgart D,Philipp T,Erbel R,Cohen MV

    更新日期:2002-12-01 00:00:00

  • From purified GPCRs to drug discovery: the promise of protein-based methodologies.

    abstract::G-protein-coupled receptors (GPCRs), the largest family of membrane proteins, represent ideal therapeutic targets for a number of disorders and diseases. Besides cell-based assays and high throughput screening (HTS), and thanks to the availability of milligram quantities of active purified receptors, protein-based app...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.04.002

    authors: Alkhalfioui F,Magnin T,Wagner R

    更新日期:2009-10-01 00:00:00

  • Vasopressin receptor antagonists: potential indications and clinical results.

    abstract::Hyponatremia is a common electrolyte disorder with the potential to cause serious neurological complications. Conventional therapies for hyponatremia have been found to be inconsistently effective. Arginine vasopressin (AVP) is etiologically critical for hyponatremia, and it has been proven that AVP receptor (AVP-R) a...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.09.009

    authors: Arai Y,Fujimori A,Sudoh K,Sasamata M

    更新日期:2007-04-01 00:00:00

  • What next for rheumatoid arthritis therapy?

    abstract::Introduction of biological agents for the treatment of the chronic inflammatory joint disease rheumatoid arthritis has reinvigorated research into this debilitating disease. These agents have been shown to both act on the signs and symptoms of disease, as well as retard the progression of joint destruction. However, t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.04.001

    authors: Blake SM,Swift BA

    更新日期:2004-06-01 00:00:00

  • Biased ligands: pathway validation for novel GPCR therapeutics.

    abstract::G protein-coupled receptors (GPCRs), in recent years, have been shown to signal via multiple distinct pathways. Furthermore, biased ligands for some receptors can differentially stimulate or inhibit these pathways versus unbiased endogenous ligands or drugs. Biased ligands can be used to gain a deeper understanding of...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.04.002

    authors: Rominger DH,Cowan CL,Gowen-MacDonald W,Violin JD

    更新日期:2014-06-01 00:00:00

  • Control of growth and development of the feto-placental unit.

    abstract::Classical gene targeting has identified many genes important for fetal and placental development. Null mutation of these genes may lead to fetal growth restriction, malformation or embryonic death. Growth restriction of epigenetic basis can predispose to adult-onset diseases. The mechanisms underlying this process, te...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00108-4

    authors: Han VK,Carter AM

    更新日期:2001-12-01 00:00:00

  • Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases.

    abstract::The metabolic syndrome constitutes a group of metabolic conditions that increase the risk of developing diseases, including cardiovascular disease (CVD) and type 2 diabetes (T2D). LXRα/β are regulators of lipogenesis, cholesterol/glucose homoeostasis and inflammatory pathways, processes that are intertwined with devel...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2010.07.003

    authors: Faulds MH,Zhao C,Dahlman-Wright K

    更新日期:2010-12-01 00:00:00

  • Promising pharmacologic innovations in treating pulmonary fibrosis.

    abstract::Idiopathic pulmonary fibrosis is the most common form of the interstitial lung diseases and is characterized by chronic progressive pulmonary parenchymal fibrosis. Although the diagnosis and pathophysiology of this disease have been better characterized over the past few years, there remains no effective therapy for t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.03.003

    authors: Bhatt N,Baran CP,Allen J,Magro C,Marsh CB

    更新日期:2006-06-01 00:00:00

  • P2X4 receptors, immunity, and sepsis.

    abstract::Sepsis is life-threatening systemic organ dysfunction caused by a deregulated host response to an infectious insult. Currently, the treatment of sepsis is limited to the use of antibiotics, fluids, and cardiovascular/respiratory support. Despite these interventions, septic mortality remains high, with reduced life qua...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.02.011

    authors: Antonioli L,Blandizzi C,Fornai M,Pacher P,Lee HT,Haskó G

    更新日期:2019-08-01 00:00:00

  • Pharmacological chaperone action on G-protein-coupled receptors.

    abstract::An increasing number of genetic diseases are found to result from mutations that lead to retention of the affected proteins in the endoplasmic reticulum, where they are recognized as misfolded by the quality control system. Several of these conformational diseases involve mutations in G-protein-coupled receptors. Rece...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.08.001

    authors: Bernier V,Bichet DG,Bouvier M

    更新日期:2004-10-01 00:00:00

  • Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome.

    abstract::Irritable bowel syndrome, which affects 5-10% of the population includes around 25% with predominantly diarrhoea (IBS-D). Several lines of evidence suggest an increase in mucosal 5-HT availability in IBS-D including a decrease in the serotonin transporter (SERT) which is also seen following acute diverticulitis. 5-HT(...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.02.005

    authors: Spiller RC

    更新日期:2011-02-01 00:00:00

  • Strontium as therapy for osteoporosis.

    abstract::Osteoporosis is characterized by low bone mass and increased susceptibility to fracture. Recent in vitro studies showed that strontium ranelate, a novel agent containing two strontium atoms, acts as an effective anti-osteoporotic drug by inhibiting bone resorption by osteoclasts and promoting osteoblast replication an...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.05.005

    authors: Marie PJ

    更新日期:2005-12-01 00:00:00

  • Aptamers as candidate therapeutics for cardiovascular indications.

    abstract::The first therapeutic aptamer was approved for human use in 2004, and a range of chemical substitutions that improve the drug-like properties of aptamers has recently been shown to increase the utility of this modality. Currently there are both anticoagulant and antithrombotic aptamers in the clinic, and additionally ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.12.005

    authors: Keefe AD,Schaub RG

    更新日期:2008-04-01 00:00:00

  • Heart failure and diabetes: role of ATM.

    abstract::Heart failure is a leading cause of death in the United States. Diabetes, also known as diabetes mellitus (DM), exponentially increases the risk of heart failure. The increase in oxidative stress and metabolic dysfunction caused by DM can lead to DNA damage and the development of diabetic cardiomyopathy. Ataxia telang...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2020.06.007

    authors: Wingard MC,Frasier CR,Singh M,Singh K

    更新日期:2020-10-01 00:00:00

  • Invasive treatment in peripheral artery disease.

    abstract::Invasive treatment in peripheral artery disease (PAD) has evolved as a viable alternative to surgical treatment. However, beyond the common pathophysiological substrate, as far as treatment is concerned, each site of atherosclerotic disease (subclavian and vertebral arteries; carotid arteries; intracranial arterial tr...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.01.013

    authors: Deftereos SG,Vrachatis DA,Tolis C,Giannopoulos G

    更新日期:2018-04-01 00:00:00

  • How does ketamine elicit a rapid antidepressant response?

    abstract::A single sub-psychotomimetic dose of ketamine, an ionotropic glutamatergic n-methyl-D-aspartate (NMDA) receptor antagonist, produces a fast-acting antidepressant response in patients suffering from major depressive disorder. Depressed patients report alleviation of core symptoms within 2 h of a single low-dose intrave...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.11.005

    authors: Kavalali ET,Monteggia LM

    更新日期:2015-02-01 00:00:00

  • SIRT1 - a metabolic sensor that controls blood vessel growth.

    abstract::Blood vessels deliver nutrients and oxygen to cells and tissues in the body. When blood supply is insufficient new vessels form to meet the metabolic tissue requirements. Several studies have examined the cellular and molecular principles of blood vessel formation, yet little is known about how vessels sense and integ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2010.01.001

    authors: Guarani V,Potente M

    更新日期:2010-04-01 00:00:00

  • Cholesterol and the development of clear-cell renal carcinoma.

    abstract::The majority of kidney cancers are clear-cell carcinomas (ccRCC), characterized by the accumulation of cholesterol, cholesterol esters, other neutral lipids and glycogen. Rather than being a passive bystander, the clear-cell phenotype is suggested to be a biomarker of deregulated cholesterol and lipid biosynthesis, wh...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.08.002

    authors: Drabkin HA,Gemmill RM

    更新日期:2012-12-01 00:00:00

  • GDNF and somatostatin in sensory neurones.

    abstract::Somatostatin (SOM) is a regulatory peptide produced throughout the central nervous system and in most major peripheral organs. In humans, the SOM stable analogue octreotide (OCT) is used to treat opioid-resistant pain. In animal models, SOM and OCT are analgesics and SOM released from the peripheral endings of sensory...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00007-3

    authors: Malcangio M

    更新日期:2003-02-01 00:00:00

  • Death in pain: peripheral nerve injury and spinal neurodegenerative mechanisms.

    abstract::A complex network operates in the spinal dorsal horn to integrate peripheral nociceptive inputs with local and descending control mechanisms, and to cross-talk with higher brain areas. Injury to peripheral sensory nerves can trigger a cascade of events within this relay which, in some cases, may turn into abnormal res...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.10.021

    authors: Berliocchi L,Russo R,Tassorelli C,Morrone LA,Bagetta G,Corasaniti MT

    更新日期:2012-02-01 00:00:00

  • Receptor classification: post genome.

    abstract::Most of the G-protein-coupled receptors (GPCRs) in the human genome have been described. Investigation will now shift from discovery to analysis. Like many other genes, those encoding GPCRs are frequently found adjacent to each other in clusters. Duplicated genes often share ligands, signalling pathways and amino acid...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00214-x

    authors: Foord SM

    更新日期:2002-10-01 00:00:00

  • Menopause, atherosclerosis, and coronary artery disease.

    abstract::Women have coronary heart disease (CHD) later than men. This review describes studies of CHD risk factors or outcomes based on studies of premenopausal women followed through the menopause transition, and prospective cohort studies of younger or older women with CHD risk markers or disease outcomes in the context of t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.01.005

    authors: Barrett-Connor E

    更新日期:2013-04-01 00:00:00